These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 37855)

  • 1. Pharmacological studies on 3-[gamma-(p-fluorobenzoyl)propyl]-2,3,4,4a,5,6-hexahydro-1-(H)-pyrazino ]1,2-a] quinoline hydrochloride (compound 69/183). Part III: Assessment of tranquillising activity.
    Singh GB; Srimal RC; Dhawan BN
    Arzneimittelforschung; 1978; 28(8):1403-6. PubMed ID: 37855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies on 3-[gamma-(p-fluorobenzoyl)propyl]-2,3,4,4a,5,6-hexahydro-1-(H)-pyrazino(1,2-a)quinoline hydrochloride (compound 69/183). Part IV: other CNS effects and acute toxicity.
    Singh GB; Srimal RC; Dhawan BN
    Arzneimittelforschung; 1978; 28(9):1641-4. PubMed ID: 582569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive and central nervous system depressant properties of 3-(gamma-p-fluorobenzoyl propyl) 2,3,4,4a,5,6-hexahydro-1(H)-pyrazino(1,2-a) quinoline hydrochloride (compound 69-183, centpyraquin).
    Singh GB; Nityanand S; Srimal RC; Rao VA; Jain PC; Dhawan BN
    Experientia; 1973 Dec; 29(12):1529-30. PubMed ID: 4203916
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological studies on 3-[gamma-(p-fluorobenzoyl)propyl]-2,3,4,4a,5,6-hexahydro-1-(H)-pyrazino (1,2-a) quinoline (compound 69/183). Part I: Hypotensive activity.
    Singh GB; Srimal RC; Nityanand S; Dhawan BN
    Arzneimittelforschung; 1978; 28(7):1087-91. PubMed ID: 114185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological studies on 3-[gamma-(p-fluorobenzoyl)propyl]-2,3,4,4a,5,6-hexahydro-1 (H)-pyrazino(1,2-a) quinoline hydrochloride (compound 69/183). Part II: Effect on cardiac dynamics.
    Srimal RC; Mason DF; Dhawan BN
    Arzneimittelforschung; 1978; 28(7):1092-5. PubMed ID: 582695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of suloctidil on the central and peripheral nervous systems].
    Nishi H; Watanabe T; Mori M
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):191-212. PubMed ID: 6319248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological studies on 2-methyl-4-amino-6-methoxy-s-triazine (CV399); with special reference to its central effects].
    Chiba S; Nagawa Y; Yui T
    Nihon Yakurigaku Zasshi; 1970; 66(1):64-75. PubMed ID: 4393359
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of azelastine hydrochloride, a novel anti-allergic drug, on the central nervous system.
    Kaneko T; Kitahara A; Ozaki S; Takizawa K; Yamatsu K
    Arzneimittelforschung; 1981; 31(8):1206-12. PubMed ID: 6117290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.
    Shintani S; Toba Y; Suzuki S; Ninomiya S; Umezato M; Hiyama T
    Arzneimittelforschung; 1985; 35(7A):1157-62. PubMed ID: 4074429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
    Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
    Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
    Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
    Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of skimmianine on animal behavior.
    Cheng JT
    Arch Int Pharmacodyn Ther; 1986 May; 281(1):35-43. PubMed ID: 3753096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuropharmacological studies on tolperisone hydrochloride (author's transl)].
    Fujii Y; Ishii Y; Suzuki T; Murayama S
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):655-68. PubMed ID: 232053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral characterization of the new potent nonselective dopamine agonist pergolide.
    Helton DR; Modlin DL; Williams PD
    Arzneimittelforschung; 1992 Jul; 42(7):885-90. PubMed ID: 1418051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavioral pharmacology of mianserin hydrochloride, a new antidepressant (author's transl)].
    Kamioka T; Sakai Y
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):533-47. PubMed ID: 7193623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of ritodrine hydrochloride on motor nervous system and central nervous system].
    Ikeda S; Tsukamoto T
    Nihon Yakurigaku Zasshi; 1984 Sep; 84(3):311-26. PubMed ID: 6500405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.